HOME >> MEDICINE >> NEWS
Yale receives $10 million to study tobacco use: Research grant comes from three national organizations

New Haven, Conn. -- Yale Medical School researchers will examine why some smokers are resistant to current smoking cessation treatments with a $10 million grant from The National Institute on Drug Abuse (NIDA), the National Cancer Institute (NCI) and The Robert Wood Johnson Foundation.

The five-year grant is part of an $84 million initiative by these three organizations to create national Transdisciplinary Tobacco Use Research Centers (TTURC) for studying tobacco use, new ways to reduce its use and combat its consequences. Led by Principal Investigator Stephanie S. O'Malley, Ph.D., Yale's new TTURC center consists of a multidisciplinary group of scientists conducting five major tobacco research projects.

"The goal of our center is to improve tobacco addiction treatment by studying why current treatments fail and developing new behavioral and drug treatments that address these factors," said O'Malley, professor of psychiatry and director of the Division of Substance Abuse Research at Yale Medical School. "It is critically important that more effective smoking cessation treatments be developed, because most smokers try to quit only once every three to four years."

Despite trends that show declining smoking rates in the general population, rates are declining less in female smokers, smokers with depression and smokers who are heavy drinkers. The five Yale studies will focus on these often-overlooked segments of the smoking population.

"Given societal pressures against smoking, the majority of current smokers are either in the process of quitting or interested in stopping, but many find it difficult to quit and are treatment resistant," said Marina Picciotto, assistant professor of psychiatry and pharmacology at Yale. "In order to treat this group of smokers, we have to increase understanding of alcohol use and depression, which are known factors in treatment failure."

The center grant provides a rare opportunity to examine these risk
'"/>

Contact: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University
17-Oct-1999


Page: 1 2 3

Related medicine news :

1. UIC professor receives international humanitarian award
2. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant
3. Epidemiologist Trichopoulos receives $5.8 million Department of Defense Innovator Award
4. GlaxoSmithKline receives unanimous favorable recommendation by FDA Advisory Committee for Boostrix
5. NYU Child Study Center receives grant from the American Red Cross September 11 recovery program
6. Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program
7. American Academy of Neurology program receives Grassroots Award
8. Orqis receives FDA approval to expand clinical trial of Cancion CRS therapy to 40 centers
9. Mayo Clinic Cancer Center receives SPORE grant for brain cancer research from NCI
10. Pfizers antifungal medicine VFEND receives FDA approval
11. Shire receives US FDA approval of EQUETRO (TM) for bipolar disorder

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, ... M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... the most handsome men, look naturally attractive. Plastic surgery should be invisible.” He ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology:
Cached News: